These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32134172)

  • 1. Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti-inflammatory and antioxidant agents to treat hair loss.
    Anzai A; Pereira AF; Malaquias KR; Guerra LO; Mercuri M
    Dermatol Ther; 2020 May; 33(3):e13293. PubMed ID: 32134172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study.
    Rossi A; Magri F; DI Fraia M; Caro G; Fortuna MC; Piacentini M; Celleno L
    Ital J Dermatol Venerol; 2022 Feb; 157(1):78-83. PubMed ID: 33878855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.
    Cedirian S; Bruni F; Quadrelli F; Caro G; Fortuna M; Rossi A; Piraccini BM; Starace M
    J Cosmet Dermatol; 2023 Dec; 22(12):3347-3351. PubMed ID: 37415302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a cosmetic phyto-caffeine shampoo in female androgenetic alopecia.
    Bussoletti C; Tolaini MV; Celleno L
    G Ital Dermatol Venereol; 2020 Aug; 155(4):492-499. PubMed ID: 29512972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium.
    Piccolo D; Crisman G; Conforti C; Buzzi M; Genovesi C; Marchi D; Mazzaracchio D; Goldust M
    Dermatol Ther; 2021 Mar; 34(2):e14799. PubMed ID: 33486860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
    Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
    Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair Shedding Evaluation for Alopecia: A Refined Wash Test.
    Li X; Wang X; Wang C; Zhang J; Zhou C
    Clin Cosmet Investig Dermatol; 2022; 15():117-126. PubMed ID: 35115799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
    Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
    Whiting DA
    J Am Acad Dermatol; 1996 Dec; 35(6):899-906. PubMed ID: 8959948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium.
    Feldman PR; Feldman OJ; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():918058. PubMed ID: 36045927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female-patterned alopecia in teenage brothers with unusual histologic features.
    Carlson JA; Malysz J; Schwartz J
    J Cutan Pathol; 2006 Nov; 33(11):741-8. PubMed ID: 17083694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogen Hairs in Women with and without Hair Loss.
    Guarrera M; Rebora A
    Skin Appendage Disord; 2017 Oct; 3(4):193-196. PubMed ID: 29177147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.